Polygenic Risk Score Modifies Breast Cancer Risk in Pathogenic Variant Carriers

Oct

How to Train Your DRAGEN for Pathology Informatics

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov

Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Nov

Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov

Featured Webinar

The Tumor Neighborhood Watch: How Spatial Architecture and Cellular Neighborhoods Correlate to Colorectal Cancer Outcomes

Most recent single-cell and spatial biology studies have focused on the network of interactions between different cell types and their spatial context.

Menu

Polygenic Risk Score Modifies Breast Cancer Risk in Pathogenic Variant Carriers

To read the full story....

Breaking News

Qiagen Reports 26 Percent Q3 Revenue Growth; Ups Full-Year Guidance

WUSTL, PercayAI to Seek COVID-19 Treatments Via AI, Deep Learning

Waters Q3 Revenues Up 3 Percent

Clonal Hematopoiesis Mutation Study Reveals Risk of Treatment-Related Cancer

Caris Life Sciences Raises $310M Through Equity, Debt Financing

Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent

Recent Headlines from
Precision Oncology News

Pfizer Turns to Health Social Network to Find Patients With Rare Lung Cancer Genetic Variants

Dual Antigen CAR T-cell Therapy Shows Benefit in Medical College of Wisconsin Study

Baylor Study Uses Immunai Single-Cell Profiling to Analyze CAR-NKT Neuroblastoma Treatment

Pfizer, Invitae Focus on Expanding Global BRCA1/2 Test Access Amid Treatment, Screening Barriers

Maine Cancer Genomics Initiative Focuses on Matching, Monitoring Patients in Studies

Featured White Papers

How to Train Your DRAGEN for Pathology Informatics

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

The Tumor Neighborhood Watch: How Spatial Architecture and Cellular Neighborhoods Correlate to Colorectal Cancer Outcomes

What's Popular?

Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent

FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies

Melanoma Treatment Stage Affects Ability of Liquid Biopsy to Predict Immunotherapy Benefit

Caris Life Sciences Raises $310M Through Equity, Debt Financing

Sponsorships